Jesse Shefferman

Jesse Shefferman is a co-founder of Protara and has led the Company since its inception through the addition of two late-stage assets, the establishment of multiple late-stage development programs and its listing on NASDAQ in early 2020. Jesse has spent over twenty years in the biopharma industry holding several strategic leadership and financial roles.

Prior to co-founding Protara, Jesse was Vice President and Head of Business Development at Retrophin Inc., a leading rare diseases company where Jesse was a member of the executive leadership team and executed a number of company-defining transactions.

Prior to Retrophin, Jesse served as Director, Strategy and Business Development at Vertex Pharmaceuticals, Inc., where he focused on hepatology and rare disease programs. Jesse previously served as an investment banker with Barclays Capital and Lehman Brothers, where he focused on providing strategic and financial advice to the management teams and boards of directors of numerous biopharmaceutical companies.

Jesse holds an MBA and Certificate in Health Sector Management from Duke University and a BA in Accounting from Gordon College.